Bruns, Heiko <br/><br/>
Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.  [electronic resource] 

 -  The Journal of clinical investigation  May 2009 
 - 1167-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI38482  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--metabolism<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--metabolism<br/>Autoimmune Diseases--therapy<br/>Blood Cell Count<br/>CD8-Positive T-Lymphocytes--cytology<br/>Complement System Proteins--immunology<br/>Cytotoxicity, Immunologic--immunology<br/>Female<br/>Humans<br/>Immunity, Cellular--immunology<br/>Immunotherapy--adverse effects<br/>Infliximab<br/>Interferon-gamma--metabolism<br/>Leukocytes, Mononuclear--immunology<br/>Male<br/>Middle Aged<br/>Monocytes--immunology<br/>Mycobacterium tuberculosis--immunology<br/>Perforin<br/>Pore Forming Cytotoxic Proteins--metabolism<br/>T-Lymphocyte Subsets--cytology<br/>Tuberculosis--immunology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Vesicular Transport Proteins--metabolism